Abstract:Emergomyces africanus is a recently identified thermally-dimorphic fungal pathogen that causes disseminated infection in people living with advanced HIV disease. Known as emergomycosis, this disseminated disease is associated with very high case fatality rates. Over the last decade, improved diagnostics and fungal identification in South Africa resulted in a dramatic increase in the number of reported cases. Although the true burden of disease is still unknown, emergomycosis is among the most frequently diagnosed dimorphic fungal infections in Southern Africa; and additional species in the genus have been identified on four continents. Little is known about the pathogenesis and the host's immune response to this emerging pathogen. Therefore, we established a murine model of pulmonary infection using a clinical isolate, E . africanus (CBS 136260). Both conidia and yeast forms caused pulmonary and disseminated infection in mice with organisms isolated in culture from lung, spleen, liver, and kidney. Wild-type C57BL/6 mice demonstrated a drop in body weight at two weeks post-infection, corresponding to a peak in fungal burden in the lung, spleen, liver, and kidney. An increase in pro-inflammatory cytokine production was detected in homogenized lung supernatants including IFN-γ, IL-1β, IL-6, IL12-p40 and IL-17 at three- and four-weeks post-infection. No significant differences in TNF, IL-12p70 and IL-10 were observed in wild-type mice between one and four-weeks post-infection. Rag-1-deficient mice, lacking mature T-and B-cells, had an increased fungal burden associated with reduced IFN-γ production. Together our data support a protective T-helper type-1 immune response to E . africanus infection. This may provide a possible explanation for the susceptibility of only a subset of people living with advanced HIV disease despite hypothesized widespread environmental exposure. In summary, we have established a novel murine model of E . africanus disease providing critical insights into the host immune components required for eliminating the infection. Emergomyces africanus is a thermally-dimorphic fungus that was recently described as the cause of disseminated infections in persons living with advanced HIV disease in South Africa, where emergomycosis is among the most frequently diagnosed dimorphic fungal diseases. Four additional Emergomyces species have been described causing serious infections around the world, and the infection has a high case fatality rate. Despite the seriousness of this infection, the pathophysiology, immunology, diagnosis, and optimal management of emergomycosis remain largely unknown, hampered by the absence of an animal model. Here, we established a mouse model of pulmonary and disseminated emergomycosis using a clinical isolate of E . africanus with the aim of investigating the host immune response. We found that infection spread from the lungs to other organs within two weeks. We describe the effector immune responses in immune-competent mice aiding in controlled infection. We also highlight the immune-modulating components lacking in immunocompromised mice that promote susceptibilty to infection. Our study provides new insights into the components of the host immune response required for controlling Emergomyces spp. infection.

Analysis of spleen of mice (Mus musculus) infected with Aspergillus nidulans identifies immune-related genes

[Differentially expressed genes in immunosuppressive and healthy mice after intranasal inoculation of Aspergillus fumigatus]

The Expression of NOD Associated Proteins in Lungs of Mice Infected with Asper-gillus Fumigatus

Innate and Adaptive Immune Responses Induced by Aspergillus Fumigatus Conidia and Hyphae

Kinetic host defense of the mice infected with Aspergillus Fumigatus .

Characterization of Aspergillus fumigatus secretome during sublethal infection of Galleria mellonella larvae

Three-Dimensional Light Sheet Fluorescence Microscopy of Lungs To Dissect Local Host Immune-Aspergillus fumigatus Interactions

Dectin-1 Mrna Expression in Lung of Different Immune Status Mice Infected with Aspergillus Fumigatus

Use of Aspergillus-pulsed DC in Mice to Enhance Their Host Defense Against Aspergillus Infection

Cluster analysis of splenocyte microRNAs in the pig reveals key signal regulators of immunomodulation in the host during acute and chronic Toxoplasma gondii infection

Transient Overexpression of Gamma Interferon Promotes Aspergillus Clearance in Invasive Pulmonary Aspergillosis

Integration of proteomics and metabolomics analysis investigate mechanism of As-induced immune injury in rat spleen

Change of the concentration of IFN-γand infectious Aspergillus organisms in lung in the model of invasive pulmonary aspergillosis

Role of excessive inflammatory response in death of immunosuppressed invasive pulmonary aspergillosis mice

Deep Sequencing Profiles MicroRNAs Related to Aspergillus Fumigatus Infection in Lung Tissues of Mice.

Factors Contributing to Sex Differences in Mice Inhaling Aspergillus fumigatus

Proteome Analysis Revealed Jak/Stat Signaling and Cytoskeleton Rearrangement Proteins in Human Lung Epithelial Cells During Interaction with Aspergillus terreus

Vitamin D Deficiency Causes Defective Resistance to Aspergillus Fumigatus in Mice Via Aggravated and Sustained Inflammation

Synaptic loss and progression in mice infected with Angiostrongylus cantonensis in the early stage

The domestic pig as human-relevant large animal model to study adaptive antifungal immune responses against airborne Aspergillus fumigatus

The pathogenesis of experimental Emergomycosis in mice